title: Should We Preclude Phase 1 Clinical Trials From Enrolling Elderly Individuals?
authors.affiliation: Senior Adult Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA. Lodovico.Balducci@Moffitt.org.
authors.forename: Lodovico
authors.initials: L
authors.lastname: Balducci
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D004347:Drug Interactions; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018579:Patient Selection
chemical_list: D000970:Antineoplastic Agents